Effect of listing strategies on utilization of antitumor necrosis factor biologics infliximab and etanercept: a cross-sectional analysis from Ontario, Canada
Fenna J, McCormack D, Kitchen S, Martins D, Gomes T, Tadrous M. J Manag Care Spec Pharm. 2021; 27(4):444-52. Epub 2021 Apr 1.